ARTICLE | Company News
EMA to review Selincro
December 22, 2011 1:21 AM UTC
EMA accepted for review an MAA from H. Lundbeck A/S (CSE:LUN) for Selincro nalmefene to treat alcohol dependence. Lundbeck has rights to the opioid receptor antagonist from Biotie Therapies Corp. (HSE...